News
Many patients value conversations with their rheumatologists and oncologists more than just reading information from a website.
Lupin partners with Zentiva Group for global commercialisation of Certolizumab Pegol biosimilar, sharing profits and investments.
5h
Everyday Health on MSN6 Reasons People Quit Their Psoriatic Arthritis Medication — and Why You Shouldn’tWhen psoriatic arthritis symptoms are under control, you may be tempted to stop taking medication. Here’s why that’s a bad idea.
As Southern Utah students get ready for another year of learning, Paradise Canyon Eye Care wants parents to remember one of ...
Rheumatoid arthritis and spondyloarthritis are long-lasting inflammatory diseases that gradually wear down joints. While ...
Claire King has played Kim Tate on and off in Emmerdale for more than 30 years - and she told how she drew on her own heartache for some of the character's most emotional scenes ...
Lymphatic drainage is said to help with everything from energy and immunity to cellulite and water retention. But does it ...
Articularis Rheumatology Specialists (ARS), a division of Articularis Healthcare Group (AHG), is pleased to announce the ...
6h
ET Now on MSN$ 50 million! Lupin signs licensing deal with European pharma company for THIS - DetailsPharma major Lupin has signed a USD 50 million agreement with a European pharmaceutical company. Lupin has entered into a ...
An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical ...
Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.
Many people with autoimmune diseases live long, active lives by working closely with their healthcare teams and making minor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results